FindTrial
Sign In

The effect of dexmedetomidine on human dendritic cells

Dexmedetomidine inhibits maturation andfunction of human cord blood-derived dendritic cells by interfering with synthesis andsecretion of IL-12 andIL-23

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-POR-15007170
Enrollment
Unknown
Registered
2015-10-03
Start date
2015-10-08
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast carcinoma

Interventions

dexmedetomidine group, dexmedetomidine plus yohimbine (dexmedetomidine inhibitor) group andcontrol group:dexmedetomidine vs dexmedetomidine plus yohimbine

Sponsors

the Third Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 32 Years

Inclusion criteria

Inclusion criteria: healthy puerperant

Exclusion criteria

Exclusion criteria: 1. endocrine diseases such as diabetes, hyperthyroidism; 2. pregnancy medication history; 3. Premature rupture of membranes

Design outcomes

Primary

MeasureTime frame
IL-12;—

Countries

China

Contacts

Public ContactWen Ouyang
ouyangwen133@vip.sina.com+86 13974934441

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026